While LDL-C, non-HDL-C, and apoB concentrations are highly correlated, there are clinical scenarios (e.g., in patients with diabetes) where LDL-C might underestimate the concentration of atherogenic apoB-containing lipoproteins. This evidence concerns the gene APOB and diabetes mellitus.